Abiopharma

🔍 Compton Charles Lacey III (Director)

Company: Fastly, Inc. (FSLY)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Sold 15,028 shares of Class A Common Stock at $23.0 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 969,814.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 35,501 shares of Class A Common Stock at $21.1 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 934,313.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 18,978 shares of Class A Common Stock at $21.86 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 915,335.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 1,100 shares of Class A Common Stock at $22.61 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 914,235.00 | transaction_form_type: 4 | Footnotes: F2, F5

Footnotes:

• F1: Shares sold to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
• F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.59 to $21.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.59 to $22.51, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.60 to $22.65, inclusive.